Autopsy report · NCT00122668
Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
Cause of deathNo reason given
Life of this trial
- Registered 1 year 8 months after it had already started.
- Ran for about 1 year 8 months before it stopped.
- 112 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Sponsor type
- Government (non-US federal)
- Conditions
- HIV Infections; HIV-Associated Lipodystrophy Syndrome
- Interventions
- non-nucleoside reverse transcriptase inhibitors; nucleoside reverse transcriptase inhibitors; protease inhibitor
- Participants
- 112
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.